QRS interval widening appears to be highly specific for the diagnosis of hyperkalemia in patients with end-stage kidney disease. ECG changes, in general, have poor sensitivities for hyperkalemia in ...

In patients with severe hyperkalemia, the Brugada syndrome ECG phenotype is associated with a high prevalence of malignant arrhythmias and all-cause mortality. Among patients with severe hyperkalemia ...

AliveCor has received approval from the Food and Drug Administration (FDA) to develop a non-invasive method of detecting high blood potassium levels. The startup, which chiefly focuses on monitoring ...

AliveCor already offers the first FDA-approved EKG reader for Apple Watch with its Kardiaband system, and a new study shows how that hardware may be capable of even more medical achievements. A new ...

NEW YORK--(BUSINESS WIRE)--AccurKardia, an innovator in ECG-based diagnostics technology, has announced the initiation of a multicenter clinical pilot of AK+ Guard TM, an FDA Breakthrough Device ...

Although serum potassium monitoring is recommended to reduce the risk of hyperkalemia, only a small percentage of patients taking RAAS inhibitors are monitored. Hyperkalemia diagnosis is often missed ...

AliveCor is working on a new application for the technology behind its KardiaBand for Apple Watch. Last year, the FDA approved KardiaBand as a medical device, and it can record your heart rhythm and ...

Newer potassium binders might have a role in treating the condition, according to a panel. Emergency management of severe hyperkalemia still is largely based on traditional practice with little ...